COMP <GO>
BBNX vs KIDS // RSI-14 & 200D SMA MOMENTUM
Beta Bionics Inc. (NASDAQ) VS. OrthoPediatrics Corp. (NASDAQ) • 15-METRIC TALLY: BBNX 3
— KIDS 7
▲ RSI-14 & 200D SMA MOMENTUM LEADER: KIDS
LAST: $16.75 (-4.72%) • MKT CAP: $955.8M
rsi-technicals
45.8
LAST: $30.87 (-2.06%) • MKT CAP: $823.0M
rsi-technicals
79.0
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (BBNX VS. KIDS)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | BBNX | KIDS | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 55.40% | 73.10% | -17.70 | KIDS | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -22.10% | -7.30% | -14.80 | KIDS | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | -5.88% | -1.94% | -3.94 | KIDS | /fcf-yield <GO> |
| Operating Margin | -60.00% | -16.60% | -43.40 | KIDS | /operating-margins <GO> |
| Net Profit Margin | -60.00% | -16.80% | -43.20 | KIDS | /net-margins <GO> |
| Revenue Growth (YoY) | 53.90% | 15.40% | +38.50 | BBNX | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 12.82 | 3.00 | +9.82 | BBNX | /balance-sheet <GO> |
| Piotroski F-Score Quality | 4/9 | 5/9 | -1.00 | KIDS | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum ACTIVE | 45.8 | 79.0 | -33.20 | KIDS | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | — | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $955.8M | $823.0M | $132.8M | BBNX | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | BBNX REV | KIDS REV | BBNX GROSS % | KIDS GROSS % | BBNX FCF | KIDS FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $100.3M | $236.3M | 55.4% | 73.1% | -$56.2M | -$16.0M |
| FY 2024 | $65.1M | $204.7M | 55.1% | 72.6% | -$51.7M | -$41.3M |
| FY 2023 | $12.0M | $148.7M | — | — | -$32.4M | -$27.0M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
BBNX // BETA —
KIDS // BETA —